Inge de Kok

The work package on capacity building (WP8) will be coordinated by Inge de Kok. Her area of expertise is the evaluation of costs and effects of medical interventions (i.e. cervical cancer screening, HPV vaccination, screening for abdominal aortic aneurysms) by using the MISCAN model. This expertise is reflected in her thesis, entitled ‘Vaccination and screening for the prevention of cervical cancer: health effects and cost-effectiveness’, as well as in publications in a variety of medical scientific journals including the British Medical Journal and the Journal of the National Cancer Institute. This work has also had impact on the practice of the Dutch national cervical cancer-screening program (change in age range and interval for screening rounds, introduction of HPV vaccination and change towards primary HPV-testing).


The project was launched in September 2015 and will continue to August 2020.

This project has received funding from the European Unionʼs Horizon2020 Programme under grant agreement no 634753